Additional information
| Dosage Form | Tablets |
|---|---|
| Specialities | Diabetologist, Physician |
| Therapeutic Segment | Anti-diabetic |
As directed by physician
Gliclazide belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Metformin exerts its prevailing, glucose-lowering effect by inhibiting hepatic gluconeogenesis and opposing the action of glucagon.
